Matthew Winton - 28 Mar 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
COO
Signature
/s/ Matthew Winton
Issuer symbol
INZY
Transactions as of
28 Mar 2024
Net transactions value
+$10,616
Form type
4
Filing time
03 Apr 2024, 17:23:00 UTC
Previous filing
15 Mar 2024
Next filing
03 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $10,616 +3,188 $3.33 3,188 28 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2023 through March 31, 2024. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on October 2, 2023, the first trading day of the purchase period.